Display options
Share it on

Can J Infect Dis. 2003 Jul;14(4):221-9. doi: 10.1155/2003/214034.

T cell costimulatory molecules in anti-viral immunity: Potential role in immunotherapeutic vaccines.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses

Tania H Watts, Edward M Bertram, Jacob Bukczynski, Tao Wen

PMID: 18159461 PMCID: PMC2094939 DOI: 10.1155/2003/214034

Abstract

T lymphocyte activation is required to eliminate or control intracellular viruses. The activation of T cells requires both an antigen specific signal, involving the recognition of a peptide/major histocompatibility protein complex by the T cell receptor, as well as additional costimulatory signals. In chronic viral diseases, T cell responses, although present, are unable to eliminate the infection. By providing antigens and costimulatory molecules together, investigators may be able to increase and broaden the immune response, resulting in better immunological control or even elimination of the infection. Recent progress in understanding the function of costimulatory molecules suggests that different costimulatory molecules are involved in initial immune responses than are involved in recall responses. These new developments have important implications for therapeutic vaccine design. In this review the authors discuss the function of T cell costimulatory molecules in immune system activation and their potential for enhancing the efficacy of therapeutic vaccines.

Keywords: Immunity; Lymphocytes; Therapeutic vaccines; Vaccination; Viral infection

References

  1. J Exp Med. 1998 Jul 6;188(1):61-70 - PubMed
  2. Curr Pharm Biotechnol. 2001 Mar;2(1):47-76 - PubMed
  3. Immunity. 1994 Sep;1(6):501-8 - PubMed
  4. Eur J Immunol. 2003 Feb;33(2):446-54 - PubMed
  5. Nature. 2001 Jan 4;409(6816):97-101 - PubMed
  6. J Biotechnol. 2000 Sep 29;83(1-2):105-13 - PubMed
  7. Nat Med. 2002 Jan;8(1):47-53 - PubMed
  8. Annu Rev Immunol. 2002;20:197-216 - PubMed
  9. Nat Immunol. 2002 Jul;3(7):611-8 - PubMed
  10. Exp Gerontol. 1994 Nov-Dec;29(6):601-9 - PubMed
  11. Science. 1995 Nov 10;270(5238):985-8 - PubMed
  12. J Virol. 2000 Aug;74(16):7320-30 - PubMed
  13. Nat Med. 2002 Apr;8(4):379-85 - PubMed
  14. Nature. 2001 Jan 4;409(6816):105-9 - PubMed
  15. J Immunol. 1999 Dec 15;163(12):6520-9 - PubMed
  16. Science. 1970 Sep 11;169(3950):1042-9 - PubMed
  17. Semin Immunol. 1998 Dec;10(6):471-80 - PubMed
  18. Immunity. 1999 Dec;11(6):699-708 - PubMed
  19. J Immunol. 2001 May 15;166(10):5864-8 - PubMed
  20. Curr Opin Immunol. 1996 Apr;8(2):278-84 - PubMed
  21. J Immunol. 1999 Jun 15;162(12):7569-77 - PubMed
  22. Nat Immunol. 2002 Aug;3(8):699-702 - PubMed
  23. Nat Immunol. 2002 Nov;3(11):1013-8 - PubMed
  24. Nature. 1999 Jan 21;397(6716):263-6 - PubMed
  25. Cell. 2001 Feb 23;104(4):487-501 - PubMed
  26. J HIV Ther. 2002 May;7(2):40-5 - PubMed
  27. JAMA. 2001 Dec 12;286(22):2787-90 - PubMed
  28. Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8597-602 - PubMed
  29. Genes Dev. 1998 Sep 15;12(18):2821-30 - PubMed
  30. J Immunol. 1993 Feb 15;150(4):1147-59 - PubMed
  31. Annu Rev Immunol. 1996;14:233-58 - PubMed
  32. J Immunol. 1999 Jun 15;162(12):6967-70 - PubMed
  33. Immunity. 1995 Nov;3(5):541-7 - PubMed
  34. J Immunol. 2002 Aug 15;169(4):1792-800 - PubMed
  35. Immunity. 1999 Aug;11(2):141-51 - PubMed
  36. Annu Rev Immunol. 2002;20:551-79 - PubMed
  37. Eur J Immunol. 1998 May;28(5):1738-42 - PubMed
  38. Annu Rev Immunol. 1998;16:111-35 - PubMed
  39. J Immunol. 2000 Dec 15;165(12):6833-9 - PubMed
  40. Nat Immunol. 2001 May;2(5):423-9 - PubMed
  41. Cell. 1992 Dec 24;71(7):1065-8 - PubMed
  42. Curr Opin Immunol. 1999 Jun;11(3):340-5 - PubMed
  43. Eur J Immunol. 2002 Dec;32(12):3376-85 - PubMed
  44. Immunity. 1998 Mar;8(3):353-62 - PubMed
  45. Science. 1993 Jul 30;261(5121):609-12 - PubMed
  46. J Infect Dis. 2001 Jun 1;183(11):1565-73 - PubMed
  47. J Exp Med. 1997 Jul 7;186(1):47-55 - PubMed
  48. J Immunol. 2002 Feb 1;168(3):991-5 - PubMed
  49. Immunity. 1997 Oct;7(4):445-50 - PubMed
  50. J Immunol. 2001 Aug 1;167(3):1313-24 - PubMed
  51. J Immunol. 1997 Jan 15;158(2):551-9 - PubMed
  52. Nat Immunol. 2002 Jul;3(7):619-26 - PubMed
  53. Immunity. 1999 Dec;11(6):689-98 - PubMed
  54. J Exp Med. 2000 Jan 17;191(2):365-74 - PubMed
  55. Science. 1996 Oct 4;274(5284):94-6 - PubMed
  56. J Exp Med. 2000 Jul 3;192(1):53-61 - PubMed
  57. J Immunol. 1999 Apr 15;162(8):5003-10 - PubMed
  58. Nature. 1998 Mar 19;392(6673):245-52 - PubMed
  59. Nat Rev Immunol. 2002 Feb;2(2):116-26 - PubMed
  60. Immunity. 1998 Feb;8(2):177-87 - PubMed
  61. Semin Immunol. 1998 Dec;10(6):481-9 - PubMed
  62. Curr Opin Immunol. 1999 Jun;11(3):286-93 - PubMed
  63. Semin Immunol. 1998 Dec;10(6):423-34 - PubMed
  64. J Immunol Methods. 2002 Oct 1;268(1):9-19 - PubMed
  65. Genes Cells. 2001 Sep;6(9):733-42 - PubMed
  66. J Immunol. 1999 Nov 1;163(9):4833-41 - PubMed
  67. Nat Immunol. 2001 May;2(5):415-22 - PubMed
  68. J Immunol. 2002 Apr 15;168(8):3777-85 - PubMed
  69. Nat Immunol. 2002 Jun;3(6):536-41 - PubMed
  70. Blood. 2001 Nov 1;98(9):2817-27 - PubMed
  71. J Immunol. 2000 Mar 1;164(5):2320-5 - PubMed
  72. Nature. 2001 Jan 4;409(6816):102-5 - PubMed

Publication Types